Authors:
JASON J
SLEEPER LA
DONFIELD SM
MURPHY J
WARRIER I
ARKIN S
EVATT B
WILLOUGHBY A
WASSERMAN J
PEQUEGNAT W
GOMPERTS E
KAUFMAN F
NELSON M
SCHULTZE ME
PEARSON S
HILGARTNER M
GERTNER J
SCIACCA J
HOOTS WK
LOVELAND K
CANTINI M
CURRY C
MCKINLAY S
DONFIELD S
MAEDER MA
CONTANT C
KISKER CT
STEHBENS J
BALE J
COOL V
ANDES WA
SIROIS P
SEXAUER C
OLSON R
BOWMAN M
HAWK S
ALEDORT L
ARROYO M
HAIRE W
ERICKSON J
PARMLEY R
MANGOS J
SCOTT A
HONECK L
LUSHER J
BAIRDCOX K
HERSHEY MS
EYSTER E
PATTISHALL E
SCHAFER J
NEAGLEY CS
SHAPIRO A
HATCHER S
DAVIGNON G
MOLLEN P
WICKLUND B
SPOOR M
Citation: J. Jason et al., EVIDENCE FOR A SHIFT FROM A TYPE-I LYMPHOCYTE PATTERN WITH HIV DISEASE PROGRESSION, Journal of acquired immune deficiency syndromes and human retrovirology, 10(4), 1995, pp. 471-476
Authors:
GRUPPO R
BRAY GL
SCHROTH P
GOMPERTS ED
ALEDORT L
Citation: R. Gruppo et al., TRANSIENT INHIBITORS IN RECIPIENTS OF RECOMBINANT FACTOR-VIII (R-FVIII) - A REPORT FROM THE RECOMBINATE(TM) STUDY OF PREVIOUSLY UNTREATED PATIENTS (PUPS), Blood, 86(10), 1995, pp. 758-758
Authors:
MANNUCCI PM
ADAMSON R
INGERSLEV J
KOPLOVE HM",CANDEL,"LUSHER J
KISKER T
DIMICHELE D
CIAVARELLA N
LAWRENCE J
ALEDORT L
GOLDSMITH JC
WHITE G
GOMPERTS E
Citation: Pm. Mannucci et al., RECOMBINATE(TM) TECHNOLOGY ISSUES - PANEL DISCUSSION, Annals of hematology, 68, 1994, pp. 190000025-190000028
Authors:
KISKER T
KASPER C
WHITE G
BRAY G
LUSHER J
MARIANI G
VERMYLEN J
CIAVARELLA N
ALEDORT L
BARROWCLIFFE T
GOMPERTS E
BERNTORP E
GIANGRANDE P
LAURIAN Y
Citation: T. Kisker et al., CLINICAL ISSUES - PANEL DISCUSSION, Annals of hematology, 68, 1994, pp. 190000039-190000043
Citation: Pj. Cagnoni et L. Aledort, GASTROINTESTINAL-BLEEDING IN HEMOPHILIA AS A COMPLICATION OF THE USE OF OVER-THE-COUNTER NONSTEROIDAL ANTIINFLAMMATORY DRUGS, American journal of hematology, 47(4), 1994, pp. 336-337
Authors:
ADDIEGO J
KASPER C
ABILDGAARD C
HILGARTNER M
LUSHER J
GLADER B
ALEDORT L
Citation: J. Addiego et al., FREQUENCY OF INHIBITOR DEVELOPMENT IN HEMOPHILIACS TREATED WITH LOW-PURITY FACTOR-VIII, Lancet, 342(8869), 1993, pp. 462-464
Citation: L. Aledort, THE IMMUNITY SYSTEM IN PATIENTS TREATED WITH RFVIII .2. APPEARANCE OFALLOANTIBODIES AGAINST FACTOR-VIII, Thrombosis research, 70, 1993, pp. 166-166